EXOSC9 antibody (C-Term)
Quick Overview for EXOSC9 antibody (C-Term) (ABIN308456)
Target
See all EXOSC9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Binding Specificity
- C-Term
-
Purpose
- PMSCL1
-
Sequence
- RTQTTSAKQE KAP
-
Specificity
- This antibody is expected to recognize both reported isoforms (NP_001029366.1, NP_005024.2).
-
Cross-Reactivity
- Human
-
Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-RTQTTSAKQEKAP , from the C Terminus of the protein sequence according to NP_001029366.1, NP_005024.2.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: Approx. 75 kDa band observed in lysates of cell line Jurkat (calculated MW of 50.8 kDa according to NP_001029366.1). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Alderuccio, J Exp Med.
Peptide ELISA: antibody detection limit dilution 1:64000.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Minimize freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- EXOSC9 (Exosome Component 9 (EXOSC9))
-
Alternative Name
- EXOSC9
-
Background
- EXOSC9, exosome component 9, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6, P75 polymyositis-scleroderma overlap syndrome associated autoantigen, PMSCL autoantigen, 75kD, autoantigen PM/Scl 1, polymyositis/scleroderma autoantigen 1 (75kD), polymyositis/sclerod
-
Gene ID
- 5393
-
NCBI Accession
- NP_001029366, NP_005024
Target
-